Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features - 23/07/20

Abstract |
Background |
Basal cell carcinomas (BCCs) with high-risk features are preferably treated by Mohs micrographic surgery. Studies have shown clinicopathologic characteristics that may predict more stages required for clearance. However, few studies have correlated such factors with the number of millimeters removed per stage.
Objective |
To determine margins necessary for BCC clearance according to tumor features, especially for tumors less than 6 mm, and to suggest initial margins for Mohs micrographic surgery and margins for wide local excision.
Methods |
Retrospective analysis of 295 consecutive Mohs micrographic surgeries for primary BCCs. Variables analyzed included patient age, sex, immunostatus, lesion size, location, histologic subtype, borders, stage number, and millimeters excised per stage.
Results |
BCCs less than 6 mm had a clearance rate of 96% with 3-mm margins. In adjusted multivariable analysis, superficial, micronodular, infiltrative, and morpheaform subtypes were associated with larger margins, whereas clinically well-defined tumors were associated with smaller margins.
Limitations |
Because of the limited sample of certain subtypes, a 3-mm margin is better suited for nodular tumors.
Conclusion |
These data help guide initial Mohs micrographic surgery and wide local excision margins required for tumor clearance according to tumor features. Nodular BCCs less than 6 mm may be cleared with 3-mm margins instead of the current 4-mm margin recommendation.
Le texte complet de cet article est disponible en PDF.Key words : basal cell carcinoma, dermoscopy, Mohs micrographic surgery, surgical margins
Abbreviation used : BCC
Plan
Funding sources: None. |
|
Conflicts of interest: None disclosed. |
|
This manuscript was submitted as an abstract for the 100th Annual Meeting of the British Association of Dermatologists (badannualmeeting.co.uk/). |
|
This clinical trial was approved by Plataforma Brasil. |
Vol 83 - N° 2
P. 493-500 - août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?